Oramed Pharmaceuticals
ORMP
#8992
Rank
โ‚ฌ0.11 B
Marketcap
2,84ย โ‚ฌ
Share price
-1.46%
Change (1 day)
34.36%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2025 (TTM): โ‚ฌ48.23 Million

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are โ‚ฌ2 Million. In 2024 the company made an earning of -โ‚ฌ12.72 Million a decrease over its 2023 earnings that were of โ‚ฌ6.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ48.23 M-479.53%
2024 -โ‚ฌ12.72 Million-311.47%
2023 โ‚ฌ6.01 M-119.45%
2022 -โ‚ฌ30.9 Million39.17%
2021 -โ‚ฌ22.21 Million73.93%
2020 -โ‚ฌ12.77 Million18.53%
2019 -โ‚ฌ10.77 Million-16.62%
2018 -โ‚ฌ12.92 Million38.32%
2017 -โ‚ฌ9.34 Million12.51%
2016 -โ‚ฌ8.3 Million25.01%
2015 -โ‚ฌ6.64 Million18.18%
2014 -โ‚ฌ5.62 Million39.72%
2013 -โ‚ฌ4.03 Million46.4%
2012 -โ‚ฌ2.75 Million128.32%
2011 -โ‚ฌ1.21 Million-51.47%
2010 -โ‚ฌ2.48 Million35.21%
2009 -โ‚ฌ1.84 Million
2007 -โ‚ฌ2.89 Million607.04%
2006 -โ‚ฌ0.41 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novo Nordisk
NVO
โ‚ฌ17.58 B 35,654.86%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚ฌ7.67 B 15,508.83%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.44 Billion-989.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚ฌ57.86 Million-217.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚ฌ23.26 Million-147.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel